Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas

被引:0
|
作者
T. Ebata
M. Yunokawa
S. Bun
A. Shimomura
T. Shimoi
M. Kodaira
K. Yonemori
C. Shimizu
Y. Fujiwara
T. Kato
K. Tamura
机构
[1] Chiba University,Department of Medical Oncology
[2] National Cancer Center Hospital,Department of Breast and Medical Oncology
[3] National Cancer Center Hospital,Department of Pharmacy
[4] National Cancer Center Hospital,Department of Gynecology
来源
关键词
Ovarian cancer; Carboplatin; Paclitaxel; Dose-dense therapy; Neoadjuvant chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1283 / 1288
页数:5
相关论文
共 50 条
  • [22] DOSE-DENSE WEEKLY PACLITAXEL AND CARBOPLATIN IS MORE COST-EFFECTIVE THAN BEVACIZUMAB PLUS TRIWEEKLY PACLITAXEL AND CARBOPLATIN FOR THE PRIMARY TREATMENT OF ADVANCED OVARIAN CANCER
    Harano, K.
    Shiroiwa, T.
    Watanabe, M.
    Suzuki, K.
    Fukuda, T.
    Watanabe, S.
    Katsumata, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 320 - 321
  • [23] A phase II trial of dose-dense (biweekly) paclitaxel plus carboplatin as neoadjuvant chemotherapy for operable breast cancer
    Zhu, T.
    Liu, C. L.
    Zhang, Y. F.
    Liu, Y. H.
    Xu, F. P.
    Zu, J.
    Zhang, G. C.
    Li, X. R.
    Liao, N.
    Wang, K.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (01) : 117 - 124
  • [24] A phase II trial of dose-dense (biweekly) paclitaxel plus carboplatin as neoadjuvant chemotherapy for operable breast cancer
    T. Zhu
    C. L. Liu
    Y. F. Zhang
    Y. H. Liu
    F. P. Xu
    J. Zu
    G. C. Zhang
    X. R. Li
    N. Liao
    K. Wang
    Breast Cancer Research and Treatment, 2016, 156 : 117 - 124
  • [25] Dose-Dense Paclitaxel With Carboplatin for Advanced Ovarian Cancer: A Feasible Treatment Alternative
    Glaze, Sarah
    Teitelbaum, Lisa
    Chu, Pamela
    Ghatage, Prafull
    Nation, Jill
    Nelson, Gregg
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2013, 35 (01) : 61 - 67
  • [26] Dose-dense Neoadjuvant Chemotherapy With Paclitaxel and Carboplatin in Cervical Cancer: Efficacy on Pathological Response
    Di Martino, Giampaolo
    Lissoni, Andrea Alberto
    Ferrari, Debora
    Di Meo, Maria Letizia
    Cosio, Stefania
    Gadducci, Angiolo
    Landoni, Fabio
    ANTICANCER RESEARCH, 2021, 41 (01) : 497 - 502
  • [27] Long-term follow-up of a randomized trial comparing conventional paclitaxel and carboplatin with dose-dense weekly paclitaxel and carboplatin in women with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: JGOG 3016 trial.
    Katsumata, Noriyuki
    Yasuda, Makoto
    Isonishi, Seiji
    Michimae, Hirofumi
    Kimura, Eizo
    Aoki, Daisuke
    Jobo, Toshiko
    Kodama, Shoji
    Terauchi, Fumitoshi
    Tsuda, Hiroshi
    Sugiyama, Toru
    Ochiai, Kazunori
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Dose-dense paclitaxel for advanced ovarian cancer
    Zeng, Yue-Can
    Wu, Rong
    Xu, Zhao-Guo
    Chi, Feng
    LANCET, 2010, 375 (9711): : 280 - 281
  • [29] DOSE-DENSE WEEKLY CARBOPLATIN AND PACLITAXEL AS NEOADJUVANT CHEMOTERAPY IN LOCALLY ADVANCED CERVICAL CANCER
    Crupano, F. M.
    Cormio, G.
    Loizzi, V.
    Del Vecchio, V.
    Fumarulo, V. V.
    Minicucci, V.
    Murgia, F.
    Grasso, S.
    Camporeale, A.
    Leone, L.
    Resta, L.
    Cicinelli, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 322 - 322
  • [30] Improved outcomes with dose-dense paclitaxel-based neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma
    Becker, David A.
    Thomas, Eric D.
    Gilbert, Allison L.
    Boone, Jonathan D.
    Straughn, J. Michael, Jr.
    Huh, Warner K.
    Bevis, Kerri S.
    Leath, Charles A., III
    Alvarez, Ronald D.
    GYNECOLOGIC ONCOLOGY, 2016, 142 (01) : 25 - 29